364 related articles for article (PubMed ID: 31165524)
1. Glucose-Responsive Composite Microneedle Patch for Hypoglycemia-Triggered Delivery of Native Glucagon.
GhavamiNejad A; Li J; Lu B; Zhou L; Lam L; Giacca A; Wu XY
Adv Mater; 2019 Jul; 31(30):e1901051. PubMed ID: 31165524
[TBL] [Abstract][Full Text] [Related]
2. Transdermal delivery of a somatostatin receptor type 2 antagonist using microneedle patch technology for hypoglycemia prevention.
GhavamiNejad A; Lu B; Samarikhalaj M; Liu JF; Mirzaie S; Pereira S; Zhou L; Giacca A; Wu XY
Drug Deliv Transl Res; 2022 Apr; 12(4):792-804. PubMed ID: 33683625
[TBL] [Abstract][Full Text] [Related]
3. "Smart" Composite Microneedle Patch Stabilizes Glucagon and Prevents Nocturnal Hypoglycemia: Experimental Studies and Molecular Dynamics Simulation.
Lu B; GhavamiNejad A; Liu JF; Li J; Mirzaie S; Giacca A; Wu XY
ACS Appl Mater Interfaces; 2022 May; 14(18):20576-20590. PubMed ID: 35471922
[TBL] [Abstract][Full Text] [Related]
4. Dual self-regulated delivery of insulin and glucagon by a hybrid patch.
Wang Z; Wang J; Li H; Yu J; Chen G; Kahkoska AR; Wu V; Zeng Y; Wen D; Miedema JR; Buse JB; Gu Z
Proc Natl Acad Sci U S A; 2020 Nov; 117(47):29512-29517. PubMed ID: 33177238
[TBL] [Abstract][Full Text] [Related]
5. On-demand transdermal insulin delivery system for type 1 diabetes therapy with no hypoglycemia risks.
Fu Y; Liu P; Chen M; Jin T; Wu H; Hei M; Wang C; Xu Y; Qian X; Zhu W
J Colloid Interface Sci; 2022 Jan; 605():582-591. PubMed ID: 34343731
[TBL] [Abstract][Full Text] [Related]
6. Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin delivery.
Yu J; Zhang Y; Ye Y; DiSanto R; Sun W; Ranson D; Ligler FS; Buse JB; Gu Z
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8260-5. PubMed ID: 26100900
[TBL] [Abstract][Full Text] [Related]
7. Glucose-Responsive Microneedle Patches for Diabetes Treatment.
Chen G; Yu J; Gu Z
J Diabetes Sci Technol; 2019 Jan; 13(1):41-48. PubMed ID: 29848105
[TBL] [Abstract][Full Text] [Related]
8. Insulin-Responsive Glucagon Delivery for Prevention of Hypoglycemia.
Yu J; Zhang Y; Sun W; Kahkoska AR; Wang J; Buse JB; Gu Z
Small; 2017 May; 13(19):. PubMed ID: 28318091
[TBL] [Abstract][Full Text] [Related]
9. Rapid Correction of the Hypoglycemia State in Nonhuman Primates Using a Glucagon Long-Dissolving Microneedle Patch.
Yu X; Wen X; Xu J; Zhou Q; Chen Y; Qu F; He M; Chang H; Zheng C
ACS Biomater Sci Eng; 2024 May; 10(5):3086-3096. PubMed ID: 38588325
[TBL] [Abstract][Full Text] [Related]
10. Glucose-responsive microneedle patch for closed-loop dual-hormone delivery in mice and pigs.
Yang C; Sheng T; Hou W; Zhang J; Cheng L; Wang H; Liu W; Wang S; Yu X; Zhang Y; Yu J; Gu Z
Sci Adv; 2022 Dec; 8(48):eadd3197. PubMed ID: 36449622
[TBL] [Abstract][Full Text] [Related]
11. A dissolving and glucose-responsive insulin-releasing microneedle patch for type 1 diabetes therapy.
Zhang Y; Wu M; Tan D; Liu Q; Xia R; Chen M; Liu Y; Xue L; Lei Y
J Mater Chem B; 2021 Jan; 9(3):648-657. PubMed ID: 33306077
[TBL] [Abstract][Full Text] [Related]
12. "Smart" Matrix Microneedle Patch Made of Self-Crosslinkable and Multifunctional Polymers for Delivering Insulin On-Demand.
Liu JF; GhavamiNejad A; Lu B; Mirzaie S; Samarikhalaj M; Giacca A; Wu XY
Adv Sci (Weinh); 2023 Oct; 10(30):e2303665. PubMed ID: 37718654
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of Mini-Dose Glucagon for Treatment of Nonsevere Hypoglycemia in Adults With Type 1 Diabetes.
Haymond MW; DuBose SN; Rickels MR; Wolpert H; Shah VN; Sherr JL; Weinstock RS; Agarwal S; Verdejo AS; Cummins MJ; Newswanger B; Beck RW;
J Clin Endocrinol Metab; 2017 Aug; 102(8):2994-3001. PubMed ID: 28591776
[TBL] [Abstract][Full Text] [Related]
14. Cross-Validation of a Glucose-Insulin-Glucagon Pharmacodynamics Model for Simulation Using Data From Patients With Type 1 Diabetes.
Wendt SL; Ranjan A; Møller JK; Schmidt S; Knudsen CB; Holst JJ; Madsbad S; Madsen H; Nørgaard K; Jørgensen JB
J Diabetes Sci Technol; 2017 Nov; 11(6):1101-1111. PubMed ID: 28654314
[TBL] [Abstract][Full Text] [Related]
15. New Fast Acting Glucagon for Recovery from Hypoglycemia, a Life-Threatening Situation: Nasal Powder and Injected Stable Solutions.
La Sala L; Pontiroli AE
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638984
[TBL] [Abstract][Full Text] [Related]
16. Cross-Linking-Density-Changeable Microneedle Patch Prepared from a Glucose-Responsive Hydrogel for Insulin Delivery.
Chen X; Yu H; Wang L; Shen D; Li C; Zhou W
ACS Biomater Sci Eng; 2021 Oct; 7(10):4870-4882. PubMed ID: 34519208
[TBL] [Abstract][Full Text] [Related]
17. Glucose-dependent insulinotropic polypeptide augments glucagon responses to hypoglycemia in type 1 diabetes.
Christensen M; Calanna S; Sparre-Ulrich AH; Kristensen PL; Rosenkilde MM; Faber J; Purrello F; van Hall G; Holst JJ; Vilsbøll T; Knop FK
Diabetes; 2015 Jan; 64(1):72-8. PubMed ID: 25053587
[TBL] [Abstract][Full Text] [Related]
18. Glucagon treatment in type 1 diabetes -with focus on restoring plasma glucose during mild hypoglycemia
.
Ranjan A
Dan Med J; 2018 Feb; 65(2):. PubMed ID: 29393039
[TBL] [Abstract][Full Text] [Related]
19. A self-adherent, bullet-shaped microneedle patch for controlled transdermal delivery of insulin.
Seong KY; Seo MS; Hwang DY; O'Cearbhaill ED; Sreenan S; Karp JM; Yang SY
J Control Release; 2017 Nov; 265():48-56. PubMed ID: 28344013
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia and H
Yu J; Qian C; Zhang Y; Cui Z; Zhu Y; Shen Q; Ligler FS; Buse JB; Gu Z
Nano Lett; 2017 Feb; 17(2):733-739. PubMed ID: 28079384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
